| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/23/2009 | WO2009001060A3 Use of compounds for preparing anti-tuberculosis agents |
| 04/23/2009 | WO2008152094A3 Substituted acetamides as modulators of the ep2 receptor |
| 04/23/2009 | WO2008152014A3 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases |
| 04/23/2009 | WO2008035192A3 Method of preparation of amorphous rabeprazole sodium |
| 04/23/2009 | US20090105485 Histone deacetylase inhibitors |
| 04/23/2009 | US20090105321 useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis, cancer and glaucoma; 4-[(1S)-1-({[1-(3-chlorobenzyl)-2,3-dihydro-1H-indol-7-yl]carbonyl}amino)ethyl]benzoic acid |
| 04/23/2009 | US20090105318 Amidoethylthioether Orexin Receptor Antagonists |
| 04/23/2009 | US20090105268 Dihydropyrimidone Multimers and Their Use as Human Neutrophil, Elastase Inhibitors |
| 04/23/2009 | US20090105252 Pyrimidine Derivatives and Their Use in Therapy as well as the Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's Disease |
| 04/23/2009 | US20090105243 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 04/23/2009 | US20090105230 Anti-inflammatory medicaments |
| 04/23/2009 | US20090105226 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans |
| 04/23/2009 | US20090105211 Inhibitors of hedgehog pathway |
| 04/23/2009 | US20090105209 BTK protein kinase inhibitors |
| 04/23/2009 | US20090105128 Cannabinoid receptor targeted agent |
| 04/23/2009 | US20090102371 Fluoranthene derivative and organic light emitting device having the same |
| 04/23/2009 | CA2703425A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors (mglurs) |
| 04/23/2009 | CA2702834A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050736A1 Imidazole derivatives, processes for preparing them and their uses |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2049529A1 Substituted diazepan orexin receptor antagonists |
| 04/22/2009 | EP2049528A2 Fungicide n-cycloalkyl-carboxamide derivatives |
| 04/22/2009 | EP2049527A2 Preparation of irbesartan |
| 04/22/2009 | EP2049526A2 2-substituted proline bis-amide orexin receptor antagonists |
| 04/22/2009 | EP2049525A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 04/22/2009 | EP2049522A2 Hepatitis c virus inhibitors |
| 04/22/2009 | EP2049521A2 Novel pyridazine derivatives |
| 04/22/2009 | EP2049520A2 Indole compounds |
| 04/22/2009 | EP2049519A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 04/22/2009 | EP2049510A1 Process for the preparation of candesartan cilexetil form i |
| 04/22/2009 | EP2049502A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 04/22/2009 | EP2049501A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2049500A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2049498A1 Pyrimidine compounds for combating pathogenic fungi and cancer |
| 04/22/2009 | EP2049497A2 Pyrimidine derivatives as hsp90 inhibitors |
| 04/22/2009 | EP2049491A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 04/22/2009 | EP2049484A1 Isoindoline derivatives for the treatment of arrhythmias |
| 04/22/2009 | EP2049477A2 Modulators of chemokine receptor activity, crystalline forms and process |
| 04/22/2009 | EP2049475A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/22/2009 | EP2049472A2 Cyclopropyl amine derivatives as histamin h3 receptor modulators |
| 04/22/2009 | EP2049116A2 Hepatitis c virus inhibitors |
| 04/22/2009 | EP1802572B1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 04/22/2009 | EP1670787A4 Cytokine inhibitors |
| 04/22/2009 | EP1592389B1 Piperazine-2-carboxamide derivatives |
| 04/22/2009 | EP1381366B1 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 04/22/2009 | CN101415687A Binding inhibitor of sphingosine-1-phosphate |
| 04/22/2009 | CN101415681A Pyridine and pyrimidine derivatives as mGluR2 antagonists |
| 04/22/2009 | CN101415679A Water-solubility CC-1065 analog and composition thereof |
| 04/22/2009 | CN101415674A Pyrrolidine derivatives as ERK inhibitors |
| 04/22/2009 | CN100480248C Malonamide derivatives as gamma-secretase inhibitors |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/22/2009 | CN100479860C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 04/21/2009 | US7521565 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1-yl)methyl]-4H-carbazol-4-one or its salt |
| 04/21/2009 | US7521555 Such as 2-(4,6-dimethoxypyrimidine-2-ylcarbonyl)acetanilide; for use as intermediate in production of agricultural chemicals and medicines; (pyrimidine-2-yl)-2-propanonee compound reacted with hydrazine compound in the presence of an acid to produce indole compound, oxidizing, reducing, deacetylation |
| 04/21/2009 | US7521554 A2B adenosine receptor antagonists |
| 04/21/2009 | US7521464 drugs have beta-amyloid peptide production inhibitory activity, such as 2-(2-benzo[b]thiophen-4-yl-acetylamino)-N-(5-phenyl-2H-pyrazol-3-yl)-propionamide, useful for treatment of Alzheimer's disease and Down's Syndrome |
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |
| 04/21/2009 | US7521453 e.g. 5-Bromo-2-(3-methylisoxazol-5-ylmethylamino)-4-(5-cyclopropyl- 1H-pyrazol-3-ylamino)pyrimidine; anticarcinogenic, antitumor agents; breast, prostate, colon cancer |
| 04/21/2009 | US7521451 e.g. 5,6-dimethyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione;intravenous, water-soluble compounds useful for manufacturing an anasthetic, sedative agents; side effect reduction |
| 04/21/2009 | US7521448 N-substituted benzimidazolyl c-Kit inhibitors |
| 04/21/2009 | US7521447 2-aza-[4.3.0]bicyclic heteroaromatic rings; useful for the treatment of inflammation, osteoarthritis, rheumatoid arthritis, psoriasis, Crohn's disease, inflammatory bowel disease, cancer, autoimmune diseases, and for the treatment of other cytokine-mediated diseases |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521396 processes for their preparation, and to their use as herbicides. |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | CA2499329C Indole-3-carboxamides as glucokinase (gk) activators |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009049305A2 5- (2-hydroxyphenyl) tetrazoles as hsp90 inhibitors against cancer |
| 04/16/2009 | WO2009048947A1 Methods of treatment of opioid tolerance, physical dependence, pain, and addiction with inhibitors of certain growth factor receptors |
| 04/16/2009 | WO2009048765A1 5-ht7 receptor antagonists |
| 04/16/2009 | WO2009048752A2 Insecticidal substituted azinyl derivatives |
| 04/16/2009 | WO2009048750A2 Insecticidal (1,3,5)-triazinyl phenyl hydrazones |
| 04/16/2009 | WO2009048101A1 Amide compound |
| 04/16/2009 | WO2009047903A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 04/16/2009 | WO2009047637A1 Novel polymorphs of bosentan |
| 04/16/2009 | WO2009047514A1 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use |
| 04/16/2009 | WO2009047359A1 Inhibitors of protein kinases |
| 04/16/2009 | WO2009047336A1 Phthalazine and pyrido [3,4-d] pyridaz ine compounds as h1 receptor antagonists |
| 04/16/2009 | WO2009047264A1 Spiropyrrolidines and their use against hcv and hiv infection |
| 04/16/2009 | WO2009047255A1 Heterobicyclic compounds as histamine h4-receptor antagonists |
| 04/16/2009 | WO2009047240A1 Indole derivatives useful as ppar activators |
| 04/16/2009 | WO2009047161A1 Chiral cis-imidazolines |
| 04/16/2009 | WO2009046804A1 Imidazole derivatives |
| 04/16/2009 | WO2009046606A1 Pyrimidinyl-propionic acid derivatives and their use as ppar agonists |
| 04/16/2009 | WO2008135795A3 Polymorphic forms of bosentan |
| 04/16/2009 | WO2008011453A3 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLβ-HSD-1 |
| 04/16/2009 | US20090099246 Veliparib crystal structure; an anticancer PARP inhibitor |
| 04/16/2009 | US20090099245 Title compound is Veliparib, a Poly(ADP-ribose) polymerase i.e. PARP inhibitor; anticancer agent |
| 04/16/2009 | US20090099223 Methods of treating hormone-related conditions using thio-oxindole derivatives |
| 04/16/2009 | US20090099219 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 04/16/2009 | US20090099209 Compounds Useful in Therapy |
| 04/16/2009 | US20090099205 Chemokine receptor binding compounds |
| 04/16/2009 | US20090099199 Organic compounds |
| 04/16/2009 | US20090099194 CXCR4 Antagonists Including Diazine And Triazine Structures For The Treatment Of Medical Disorders |
| 04/16/2009 | US20090099192 Substituted 1H-pyrrole-2,5-diones |
| 04/16/2009 | US20090099189 CRTH2 Receptor Ligands For Medicinal Uses |
| 04/16/2009 | US20090099183 Pyrimidines and uses thereof |
| 04/16/2009 | US20090099182 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/16/2009 | US20090099180 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |